C.M. Bidwell & Associates’s Colgate-Palmolive CL Stock Holding History

C.M. Bidwell & Associates’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-42	Closed	-$4.36K	–	497
2024 Q3	$4.36K	Buy	+42	New	+$4.28K	﹤0.01%	350

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

C.M. Bidwell & Associates's CL Position: Q4 2024 in Review

C.M. Bidwell & Associates sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 42 shares — an estimated $4.36K sold.

C.M. Bidwell & Associates first reported a position in CL in Q3 2024 and held it in 1 quarter. The position peaked at $4.36K in Q3 2024. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

C.M. Bidwell & Associates reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
C.M. Bidwell & Associates sold 42 Colgate-Palmolive shares in Q4 2024, an estimated $4.36K.
C.M. Bidwell & Associates first reported a position in Colgate-Palmolive in Q3 2024 and held it in 1 quarter.
C.M. Bidwell & Associates's Colgate-Palmolive position peaked at $4.36K in Q3 2024.
1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.